Breckenridge Pharma

News

Click on news to view details.

Zolpidem Tartrate Extended-Release Tablets, USP (generic for Ambien® CR) launch

[ July 08, 2021 ]

Multi-Product Agreement With Welding GmbH & Co, K.G.

[ July 02, 2021 ]

Breckenridge Signs Multi-Product Agreement With Aggrega Pharma LLC

[ June 22, 2021 ]

Carfilzomib Approval Generic Kyprolis

[ June 15, 2021 ]

Everolimus / Zortress Approval 06-01-2021

[ June 01, 2021 ]

Breckenridge Announces Final Approval of its ANDA for Everolimus Tablets (generic for Afinitor®)

[ March 08, 2021 ]

Breckenridge Announces Final Approval of its ANDA for Asenapine Sublingual Tablets, 5 mg Strength (generic for Saphris®)

[ March 08, 2021 ]

Breckenridge Announces Final Approval of its ANDA for Asenapine Sublingual Tablets, 2.5 and 10mg Strengths (generic for Saphris®)

[ December 11, 2020 ]

Breckenridge Announces Final Approval of its ANDA for Pomalidomide Capsules (generic for Pomalyst®)

[ November 13, 2020 ]

Towa completes acquisition of Esteve's Generic Division

[ January 31, 2020 ]

1

View All News

View Archrive News